Drug Use Investigation for LAMICTAL
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2016
At a glance
- Drugs Lamotrigine (Primary)
- Indications Lennox-Gastaut syndrome; Partial epilepsies; Tonic-clonic epilepsy
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 08 Nov 2016 Status changed from active, no longer recruiting to completed.
- 19 Apr 2015 Planned End Date changed from 1 May 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.
- 08 Jun 2014 Planned End Date changed from 1 Apr 2016 to 1 May 2016 as reported by ClinicalTrials.gov record.